Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
SC27 - P53 and KRAS Mutations in NSCLC
- Type: Science Session
- Track: Biology/Pathology
- Presentations: 5
- Moderators:F. De Marinis
- Coordinates: 12/07/2016, 11:00 - 12:30, Strauss 3
-
+
SC27.01 - The Role of p53 in Lung Cancer
11:00 - 11:20 | Author(s): P. Hainaut
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC27.02 - Biology of KRAS Mutations
11:20 - 11:40 | Author(s): J. Tímár
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC27.03 - Transforming KRAS into a Clinically Relevant Biomarker
11:40 - 12:00 | Author(s): K. O’byrne
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC27.04 - KRAS-Directed Drug Therapy in Advanced NSCLC
12:00 - 12:20 | Author(s): P. Jänne
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC27.05 - Q&A
12:20 - 12:30
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
SC28 - Novel Clinical Trial Designs
- Type: Science Session
- Track: Trial Design/Statistics
- Presentations: 5
- Moderators:S. Michiels
- Coordinates: 12/07/2016, 11:00 - 12:30, Lehar 1-2
-
+
SC28.01 - Phase I Trials of Targeted Therapies
11:00 - 11:20 | Author(s): A. Adjei
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC28.02 - Umbrella and Basket Designs
11:20 - 11:40 | Author(s): D. Tan
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC28.03 - Biomarker “Test and Validation” Designs
11:40 - 12:00 | Author(s): M. Redman
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC28.04 - Adaptive Clinical Trial Designs
12:00 - 12:20 | Author(s): V. Papadimitrakopoulou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC28.05 - Q&A
12:20 - 12:30
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
SC29 - Access, Value Assessments and Affordability of Novel Therapies
- Type: Science Session
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 5
- Moderators:M. Krzakowski
- Coordinates: 12/07/2016, 11:00 - 12:30, Strauss 1
-
+
SC29.01 - Affordability of Novel Therapies: A Global Challenge
11:00 - 11:20 | Author(s): R. Sullivan
- Abstract
No abstract available for this presentation
-
+
SC29.02 - Value-Based Assessments in Lung Cancer Therapy: The North American Perspective
11:20 - 11:40 | Author(s): R.J. Kelly
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC29.03 - Value-based Assessments in Lung Cancer Therapy: The ESMO Perspective
11:40 - 12:00 | Author(s): N. Cherny
- Abstract
Loading... -
+
SC29.04 - Solutions for Low-Income Countries
12:00 - 12:15 | Author(s): G. Lopes
- Abstract
No abstract available for this presentation
-
+
SC29.05 - The Thai Experience to Overcome High Cost Drug in Cancer
12:15 - 12:30 | Author(s): S. Thongprasert
- Abstract
Loading...
-
+
ISS12 - Immuno–Oncology: A Renaissance in the Treatment of Lung Cancer – MSD Oncology
- Type: Industry Supported Symposium
- Track:
- Presentations: 7
- Moderators:D.P. Carbone
- Coordinates: 12/07/2016, 12:45 - 14:15, Lehar 3-4
-
+
ISS12.01 - Welcome and Opening Remarks
12:45 - 12:50 | Author(s): D.P. Carbone
- Abstract
No abstract available for this presentation
-
+
ISS12.02 - Immunotherapy Experience in Lung Cancer
12:50 - 13:05 | Author(s): N. Rizvi
- Abstract
No abstract available for this presentation
-
+
ISS12.03 - The Value of OD-L1 Expression in NSCLC
13:05 - 13:20 | Author(s): K. Kerr
- Abstract
No abstract available for this presentation
-
+
ISS12.04 - Patient Management
13:20 - 13:35 | Author(s): T. Newsom-Davis
- Abstract
No abstract available for this presentation
-
+
ISS12.05 - Lung Cancer Landscape: Future Directions
13:35 - 13:50 | Author(s): D.P. Carbone
- Abstract
No abstract available for this presentation
-
+
ISS12.06 - Panel Discussion
13:50 - 14:15
- Abstract
No abstract available for this presentation
-
+
ISS12.07 - Closing Remarks
14:15 - 14:15 | Author(s): D.P. Carbone
- Abstract
No abstract available for this presentation
-
+
MA15 - Immunotherapy Prediction
- Type: Mini Oral Session
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 12
- Moderators:O. Arrieta
- Coordinates: 12/07/2016, 14:20 - 15:50, Schubert 1
-
+
MA15.01 - Immunogram for Cancer-Immunity Cycle towards Personalized Immunotherapy of Lung Cancer
14:20 - 14:26 | Author(s): T. Karasaki
- Abstract
Loading... -
+
MA15.02 - Non-Synonymous Mutation Burden in Lung Carcinoma is Associated with Durable Clinical Response to Immune Checkpoint Blockade
14:26 - 14:32 | Author(s): N.R. Mahadevan
- Abstract
Loading... -
+
MA15.03 - The Predictive Value of Mutation/Neoantigen Burden from ctDNA on the Efficacy of PD-1 Blockade in Advanced NSCLC
14:32 - 14:38 | Author(s): W. Cai
- Abstract
Loading... -
+
MA15.04 - Discussant for MA15.01, MA15.02, MA15.03
14:38 - 14:50 | Author(s): J. Fischer
- Abstract
No abstract available for this presentation
-
+
MA15.05 - PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC)
14:50 - 14:56 | Author(s): D. Krenbek
- Abstract
Loading... -
+
MA15.06 - Predictive Value of Measuring Somatic Mutations and Tumor Infiltrating Lymphocytes for PD-1 Axis Therapy in Non-Small Cell Lung Cancer (NSCLC)
14:56 - 15:02 | Author(s): S.N. Gettinger
- Abstract
Loading... -
+
MA15.07 - Molecular Determinants of Lack of Tumor Immune Infiltration in NSCLC
15:02 - 15:08 | Author(s): S. Olugbile
- Abstract
Loading... -
+
MA15.08 - Discussant for MA15.05, MA15.06, MA15.07
15:08 - 15:20 | Author(s): I. Kern
- Abstract
No abstract available for this presentation
-
+
MA15.09 - Response to the Treatment Immediately before Nivolumab Monotherapy May Predict Clinical Response to Nivolumab
15:20 - 15:26 | Author(s): H. Kobayashi
- Abstract
Loading... -
+
MA15.10 - Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma
15:26 - 15:32 | Author(s): Z. Dong
- Abstract
Loading... -
+
MA15.11 - Acquired Resistance Mechanisms to EGFR Kinase Inhibitors Alter PD-L1 Expression Status in Lung Cancer
15:32 - 15:38 | Author(s): K. Suda
- Abstract
Loading... -
+
MA15.12 - Discussant for MA15.09, MA15.10, MA15.11
15:38 - 15:50 | Author(s): M. Früh
- Abstract
No abstract available for this presentation
-
+
MA16 - Novel Strategies in Targeted Therapy
- Type: Mini Oral Session
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 12
- Moderators:G. Purkalne
- Coordinates: 12/07/2016, 14:20 - 15:50, Strauss 2
-
+
MA16.01 - Targeted Gene Therapy for Tobacco Carcinogen-Induced Lung Cancer
14:20 - 14:26 | Author(s): N. Gankhuyag
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA16.03 - Global RET Registry (GLORY): Activity of RET-Directed Targeted Therapies in RET-Rearranged Lung Cancers
14:26 - 14:32 | Author(s): O. Gautschi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA16.04 - Discussant for MA16.01, MA16.02, MA16.03
14:32 - 14:44 | Author(s): M. Ahn
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA16.05 - For EGFR Mutant Non-Small Cell Lung Cancer, Treatment Sequence Matters?
14:44 - 14:50 | Author(s): H.J. An
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA16.06 - Phase I/II Study of AC0010, Mutant-Selective EGFR Inhibitor, in Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR T790M Mutation
14:50 - 14:56 | Author(s): Y.-. Wu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA16.07 - Drug Repurposing to Overcome De Novo Resistance of Non-Traditional EGFR Mutations
14:56 - 15:02 | Author(s): J.P. Robichaux
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA16.08 - Discussant for MA16.05, MA16.06, MA16.07
15:02 - 15:14 | Author(s): T. Reungwetwattana
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA16.09 - Antitumor Activity and Safety of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer
15:14 - 15:20 | Author(s): A. Drilon
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA16.10 - Lung-MAP (S1400) Lung Master Protocol: Accrual and Genomic Screening Updates
15:20 - 15:26 | Author(s): V. Papadimitrakopoulou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA16.11 - CNS Response to Osimertinib in Patients with T790M-Positive Advanced NSCLC: Pooled Data from Two Phase II Trials
15:26 - 15:32 | Author(s): G. Goss
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA16.12 - Discussant for MA16.09, MA16.10, MA16.11
15:32 - 15:44 | Author(s): E.S. Santos
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA16.02 - Mutational Landscape of TKI Naïve and Resistant EGFR Mutant Lung Adenocarcinomas
15:44 - 15:50 | Author(s): K. Hastings
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA17 - Genetic Drivers
- Type: Mini Oral Session
- Track: Biology/Pathology
- Presentations: 12
- Moderators:M. Satouchi
- Coordinates: 12/07/2016, 14:20 - 15:50, Lehar 1-2
-
+
MA17.01 - Microarray Identification of Genetic Drivers of Brain Metastasis in Lung Adenocarcinoma
14:20 - 14:26 | Author(s): G.A. Woodard
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA17.02 - Genome-Wide Copy Number and Mutational Analysis in Longitudinal Biopsies of Matched Primary and Metastatic Pulmonary Adenocarcinomas
14:26 - 14:32 | Author(s): T. Lorber
- Abstract
Loading...Information from this presentation has been removed upon request of the author.
-
+
MA17.03 - Identifying Genomic Alteration and Inter-Tumor Heterogeneity of Multiple Primary Lung Cancers by Targeted NGS of Tumor Tissue and ctDNA
14:32 - 14:38 | Author(s): K. Chen
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA17.04 - Discussant for MA17.01, MA17.02, MA17.03
14:38 - 14:50 | Author(s): J. Tímár
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA17.05 - Evolutionary Trajectories of Molecular Progression in Different Subtypes of Primary Lung Adenocarcinomas
14:50 - 14:56 | Author(s): H. Zhai
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA17.06 - Landscape of Somatic Mutations Involving Lung Cancer Associated Genes in Non-Small Cell Lung Cancer (NSCLC) Patient-Derived Xenografts
14:56 - 15:02 | Author(s): V. Raghavan
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA17.07 - Circulating Tumor DNA Detects Minimal Residual Disease and Predicts Outcome in Localized Lung Cancer
15:02 - 15:08 | Author(s): A. Chaudhuri
- Abstract
Loading...Information from this presentation has been removed upon request of the author.
-
+
MA17.08 - Discussant for MA17.05, MA17.06, MA17.07
15:08 - 15:20 | Author(s): L. Müllauer
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA17.09 - Premature Fibroblast Senescence in Large Cell Carcinoma Provides Enhanced Growth and Invasive Advantages to Cancer Cells in Culture and in vivo
15:20 - 15:26 | Author(s): R. Lugo
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA17.10 - YES1 Kinase is a New Therapeutic Target in Non-small Cell Lung Cancer
15:26 - 15:32 | Author(s): J. Agorreta
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA17.11 - Knockdown of Akt2 Suppresses Tumorigenesis and Raf1 Overexpression Offsets This Effect in Non-Small Cell Lung Cancer
15:32 - 15:38 | Author(s): S. Zhao
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MA17.12 - Discussant for MA17.09, MA17.10, MA17.11
15:38 - 15:50 | Author(s): S. Dacic
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA22 - Novel Trials and Biomarkers in Malignant Pleural Mesothelioma
- Type: Oral Session
- Track: Mesothelioma/Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Presentations: 8
- Moderators:H. Pass
- Coordinates: 12/07/2016, 14:20 - 15:50, Strauss 3
-
+
OA22.01 - STELLAR - Interim Results of a Phase 2 Trial of TTFields with Chemotherapy for First Line Treatment of Malignant Mesothelioma
14:20 - 14:30 | Author(s): F. Grosso
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA22.02 - Nintedanib plus Pemetrexed/Cisplatin in Patients with MPM: Phase II Findings from the Placebo-Controlled LUME-Meso Trial
14:30 - 14:40 | Author(s): F. Grosso
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA22.03 - HMGB1, a Target for Mesothelioma Therapy and a Biomarker to Detect Asbestos Exposure and to Identify Mesothelioma Patients
14:40 - 14:50 | Author(s): H. Yang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA22.04 - Discussant for OA22.01, OA22.02, OA22.03
14:50 - 15:05 | Author(s): C. Rolfo
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA22.06 - Refinement of the Prognostic miR-Score for Use in Diagnostic Specimens from Chemo-Naïve Malignant Pleural Mesothelioma Patients
15:05 - 15:15 | Author(s): M.B. Kirschner
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA22.07 - Correlation of CT Scan Based Tumor Volume Measurement to Actual Resected Tumor Volume - A New T-Factor?
15:15 - 15:25 | Author(s): O. Lauk
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA22.08 - Discussant for OA22.05, OA22.06, OA22.07
15:25 - 15:40 | Author(s): V. Laszlo
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA22.05 - Breath Analysis by Gas Chromatography-Mass Spectrometry Can Be Used to Screen for Pleural Mesothelioma
15:40 - 15:50 | Author(s): K. Lamote
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA23 - EGFR Targeted Therapies in Advanced NSCLC
- Type: Oral Session
- Track: Advanced NSCLC
- Presentations: 8
- Moderators:O.T. Brustugun
- Coordinates: 12/07/2016, 14:20 - 15:50, Stolz 2
-
+
OA23.01 - Anti-EGFR Monoclonal Antibodies plus Chemotherapy in the First-Line Treatment of Advanced NSCLC: A Meta-Analysis
14:20 - 14:30 | Author(s): G. Stock
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA23.02 - Efficacy and Safety of Necitumumab Continuation Monotherapy in Patients with EGFR-Expressing Tumors in SQUIRE, a Phase 3 Study
14:30 - 14:40 | Author(s): T.E. Ciuleanu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA23.03 - Second-Line Afatinib for Advanced Squamous Cell Carcinoma of the Lung: Analysis of Afatinib Long-Term Responders in the Phase III LUX-Lung 8 Trial
14:40 - 14:50 | Author(s): G. Goss
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA23.04 - Discussant for OA23.01, OA23.02, OA23.03
14:50 - 15:05 | Author(s): M. Sebastian
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA23.05 - First-Line Afatinib versus Gefitinib in EGFRm+ Advanced NSCLC: Updated Overall Survival Analysis of LUX-Lung 7
15:05 - 15:15 | Author(s): K. Park
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA23.06 - Overall Survival (OS) of EGFR Mutation Positive Non-Small Cell Lung Cancer Patients: Real-World Treatment Patterns of 1,660 Japanese Patients
15:15 - 15:25 | Author(s): K. Yoshida
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA23.07 - Analysis of Outcomes in US IRESSA Clinical Access Program (ICAP) Patients on Gefitinib for More Than 10 Years
15:25 - 15:35 | Author(s): F.R. Hirsch
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA23.08 - Discussant for OA23.05, OA23.06, OA23.07
15:35 - 15:50 | Author(s): M.L. Johnson
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA24 - Radiotherapy of Lung Cancer: Recent Developments
- Type: Oral Session
- Track: Radiotherapy
- Presentations: 8
- Moderators:K. Dieckmann
- Coordinates: 12/07/2016, 14:20 - 15:50, Stolz 1
-
+
OA24.01 - Radiotherapy Quality Assurance of Concurrent Chemoradiotherapy in PROCLAIM Phase III Trial
14:20 - 14:30 | Author(s): A.M. Brade
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA24.02 - Locally Advanced Non-Small Cell Lung Cancer: RadioTherapy with Adaptive Strategy (LARTIA Trial)
14:30 - 14:40 | Author(s): S. Ramella
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA24.03 - Cardiac Toxicity after Radiation for Stage III NSCLC: Pooled Analysis of Dose-Escalation Trials Delivering 70-90 Gy
14:40 - 14:50 | Author(s): K. Wang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA24.04 - Discussant for OA24.01, OA24.02, OA24.03
14:50 - 15:05 | Author(s): F. McDonald
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA24.05 - The Nordic HILUS-Trial - First Report of a Phase II Trial of SBRT of Centrally Located Lung Tumors
15:05 - 15:15 | Author(s): K. Lindberg
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA24.06 - Histologic Subtype of Early-Stage Lung Adenocarcinoma is a Predictor of Failure Patterns after Stereotactic Body Radiation Therapy
15:15 - 15:25 | Author(s): J.E. Leeman
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA24.07 - The Impact of Population Heterogeneity on the Efficacy of SBRT to the Lung
15:25 - 15:35 | Author(s): N. Woody
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
OA24.08 - Discussant for OA24.05, OA24.06, OA24.07
15:35 - 15:50 | Author(s): F.(. Kong
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
first
prev
